Hans Luppa
Hans Luppa publishes mostly in Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology, on topics such as Cholinesterase and Neurodegenerative Diseases, Metabolism and Genetic Disorders and Enzyme function and inhibition.
- World rank
- #6,450,595 of 7,710,434 ranked researchers
- Rank in Germany
- #325,004 of 364,343
- Works
- 48
- Citations
- 289
- Citations per work
- 6.0
What does Hans Luppa research?
Hans Luppa's work is mostly in Biochemistry, Genetics and Molecular Biology (25%), Neuroscience (10%), Medicine (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2246.8%
- Life Sciences1939.7%
- Health Sciences59.5%
- Medicine59.5%
- Physical Sciences24.0%
- Computer Science24.0%
- 1Molecular Biology21% of their works
- 2Cellular and Molecular Neuroscience10% of their works
- 3Pharmacology10% of their works
- 4Immunology5% of their works
- 5Clinical Biochemistry5% of their works
- 6Computational Theory and Mathematics4% of their works
Research topics
- Cholinesterase and Neurodegenerative Diseases
- Metabolism and Genetic Disorders
- Enzyme function and inhibition
- Neuroscience and Neuropharmacology Research
- Computational Drug Discovery Methods
- Phosphodiesterase function and regulation
- Adenosine and Purinergic Signaling
- Pharmacological Effects and Toxicity Studies
Which keywords describe Hans Luppa's research?
The keywords of their largest research topics: Acetylcholinesterase, Cholinesterase Inhibitors, Therapeutic Targets, Biochemical Genetics, Metabolic Disorders, Carbonic Anhydrases, Inhibitors and Molecular Docking.
- Purinergic Signalling
- Cyclic Nucleotide Phosphodiesterases
- Adenosine Receptors
- Synaptic Plasticity
- Molecular Docking
- Carbonic Anhydrases
- Biochemical Genetics
- Cholinesterase Inhibitors
- Acetylcholinesterase
- Therapeutic Targets
- Metabolic Disorders
- Inhibitors
- Neurotransmission
- Virtual Screening
- Antiepileptic Drugs
- Prenatal Exposure
- cAMP Signaling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Acetylcholinesterase101 topic
- Cholinesterase Inhibitors101 topic
- Therapeutic Targets82 topics
- Biochemical Genetics61 topic
- Metabolic Disorders61 topic
- Carbonic Anhydrases51 topic
- Inhibitors51 topic
- Molecular Docking51 topic
- Neurotransmission51 topic
- Synaptic Plasticity51 topic
- Virtual Screening51 topic
- Adenosine Receptors41 topic
- Antiepileptic Drugs41 topic
- Cyclic Nucleotide Phosphodiesterases41 topic
- Prenatal Exposure41 topic
- Purinergic Signalling41 topic
- cAMP Signaling41 topic
Where does Hans Luppa work?
Hans Luppa's main affiliation in the publication record is Leipzig University, Germany.
How many publications and citations does Hans Luppa have?
OpenAlex counts 48 works and 289 citations for Hans Luppa, an h-index of 9, ranking #6,450,595 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hans Luppa. Posts are plain text and can be reported.